Williams Linda S, Bakas Tamilyn, Brizendine Edward, Plue Laurie, Tu Wanzhu, Hendrie Hugh, Kroenke Kurt
Health Services Research and Development Service, Roudebush VAMC, 1481 W. 10th St, 11-H, Indianapolis, Indiana 46202, USA.
Stroke. 2006 Aug;37(8):2081-5. doi: 10.1161/01.STR.0000230583.10311.9f. Epub 2006 Jun 29.
Proxy respondents are often needed to report outcomes in stroke survivors, but they typically systematically rate impairments worse than patients themselves. The magnitude of this difference, the degree of agreement between patients and proxies, and the factors influencing agreement are not well known.
We compared patient and family proxy health-related quality of life (HRQL) responses in 225 patient-proxy pairs enrolled in a clinical trial for poststroke depression. We used paired t-tests and the intraclass correlation (ICC) statistic to evaluate the agreement between patient and proxy domain scores and the overall Stroke-specific Quality of Life (SS-QOL) score. We used multivariate linear regression to model patient- and proxy-reported SS-QOL scores.
Patients were older (63 versus 55 years) and less often female (48% versus 74%) than proxies. Proxies rated all domains of SS-SQOL slightly worse than patients. The Mood, Energy, and Thinking domains had the greatest disparity with mean patient-proxy differences of 0.45, 0.37, and 0.37 points, respectively. The ICC for each domain ranged from 0.30 (role function) to 0.59 (physical function). Proxy overall SS-QOL score was also lower (worse) than patient score (3.7 versus 3.4, P<0.001) with ICC of 0.41. Agreement was higher among patient-proxy pairs with higher patient depression scores and with lower proxy report of caregiving burden.
Proxies systematically report more dysfunction in multiple aspects of HRQL than stroke patients themselves. Agreement between patient and proxy HRQL domain scores is modest at best and is affected by patient depression and proxy perception of burden. These differences may be large enough to impact the outcome assessment in stroke clinical trials.
在中风幸存者中报告结局通常需要代理受访者,但他们通常会系统性地将损伤程度评估得比患者本人更严重。这种差异的大小、患者与代理之间的一致程度以及影响一致程度的因素尚不清楚。
我们比较了参与中风后抑郁症临床试验的225对患者-代理对中患者和家庭代理与健康相关的生活质量(HRQL)的回答。我们使用配对t检验和组内相关系数(ICC)统计量来评估患者和代理领域得分以及总体特定于中风的生活质量(SS-QOL)得分之间的一致性。我们使用多元线性回归对患者和代理报告的SS-QOL得分进行建模。
患者比代理年龄更大(63岁对55岁),女性比例更低(48%对74%)。代理对SS-SQOL的所有领域的评分都略低于患者。情绪、精力和思维领域的差异最大,患者-代理平均差异分别为0.45、0.37和0.37分。每个领域的ICC范围从0.30(角色功能)到0.59(身体功能)。代理总体SS-QOL得分也低于患者得分(3.7对3.4,P<0.001),ICC为0.41。在患者抑郁得分较高且代理报告的护理负担较低的患者-代理对中,一致性更高。
代理系统性地报告出HRQL多个方面的功能障碍比中风患者本人更多。患者和代理HRQL领域得分之间的一致性充其量只是中等,并且受到患者抑郁和代理对负担的认知的影响。这些差异可能大到足以影响中风临床试验的结局评估。